3080.T
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.
Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products to consumers.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.2, indicating a conservative leverage position. However, the company reported negative net income of -201,795,000 JPY and negative operating income of -124,099,000 JPY, which suggests financial stress. The liquidity position is supported by a high cash and equivalents balance of 3,807,998,000 JPY, but the free cash flow is negative at -435,880,000 JPY, indicating cash outflows from operations after capital expenditures.
Profitability metrics are weak, with a return on equity of -3.4% and a return on assets of -1.86%. These figures are below the typical performance of the Food Retail & Distribution industry, which is expected to maintain stable returns due to its non-cyclical nature. The company's operating margin is also underperforming, with a gross profit of 7,416,331,000 JPY on total revenue of 28,604,828,000 JPY, translating to a gross margin of approximately 25.9%.
The company's revenue is concentrated in a single business segment, as disclosed in the financial snapshot, with no specific geographic breakdown provided. This lack of diversification may expose the company to regional economic fluctuations. The absence of segment-specific data limits the ability to assess the performance of different parts of the business.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The negative operating and net income figures suggest a challenging operating environment, potentially due to increased competition or cost pressures. The company's capital expenditures of -320,098,000 JPY indicate ongoing investment, but the negative free cash flow suggests that these investments are not yet generating positive returns.
Risk factors include the company's negative earnings and the potential for further financial stress if operating conditions do not improve. The risk assessment indicates low dilution and liquidity risks, but the absence of immediate filing-based flags does not preclude future dilution if the company requires additional capital. The company's financial flexibility is constrained by its negative cash flow from operations.
Recent events, as reflected in the financial data, include a decline in profitability and a negative earnings report. The company's last actual EPS was -15.75 JPY, and the last actual revenue was 28,604,830,000 JPY. These figures suggest a challenging period for the company, with no immediate signs of improvement in the financial statements.
- The company is operating in a non-cyclical industry but is currently experiencing financial stress with negative net and operating income.
- The company's capital structure is conservative, with a low debt-to-equity ratio, but its liquidity is supported by a high cash balance.
- Profitability metrics are weak, with a negative return on equity and assets, indicating poor performance relative to industry expectations.
- The company's growth trajectory is uncertain, with no clear signs of improvement in the financial data.
- The company's risk profile is low in terms of dilution and liquidity, but its financial performance suggests potential for further financial stress.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 3080.T Market data — financials · 2026-05-26
- Jason Co Ltd Market data — analyst estimates · 2026-05-26